{"count": 3, "results": [{"_id": "30314487", "pmid": 30314487, "pmcid": "PMC6186060", "title": "Potential drug-drug interactions in outpatient department of a tertiary care hospital in Pakistan: a cross-sectional study", "journal": "BMC Health Serv Res", "authors": ["Ismail M", "Noor S", "Harram U", "Haq I", "Haider I", "Khadim F", "Khan Q", "Ali Z", "Muhammad T", "Asif M"], "date": "2018-10-10T00:00:00Z", "doi": "10.1186/s12913-018-3579-7", "meta_date_publication": "2018 Oct 10", "meta_volume": "18", "meta_issue": "1", "meta_pages": "762", "score": 50066.36, "text_hl": "...@<m>DISEASE_Ototoxicity</m> @DISEASE_MESH:D000081015 @@@pDDIs@@@", "citations": {"NLM": "Ismail M, Noor S, Harram U, Haq I, Haider I, Khadim F, Khan Q, Ali Z, Muhammad T, Asif M. Potential drug-drug interactions in outpatient department of a tertiary care hospital in Pakistan: a cross-sectional study BMC Health Serv Res. 2018 Oct 10;18(1):762. PMID: 30314487", "BibTeX": "@article{30314487, title={Potential drug-drug interactions in outpatient department of a tertiary care hospital in Pakistan: a cross-sectional study}, author={Ismail M and Noor S and Harram U and Haq I and Haider I and Khadim F and Khan Q and Ali Z and Muhammad T and Asif M}, journal={BMC Health Serv Res}, volume={18}, number={1}, pages={762}}"}}, {"_id": "17458043", "pmid": 17458043, "title": "Ivabradine: new drug. Best avoided in stable angina.", "journal": "Prescrire Int", "date": "2007-04-01T00:00:00Z", "meta_date_publication": "2007 Apr", "meta_volume": "16", "meta_issue": "88", "meta_pages": "53-6", "score": 50047.344, "text_hl": "It was approved for sale in Europe through the centralised procedure for second-line treatment of @DISEASE_Angina_Stable @DISEASE_MESH:D060050 @@@stable angina@@@. (3) Clinical evaluation of @CHEMICAL_Ivabradine @CHEMICAL_MESH:D000077550 @@@ivabradine@@@ only includes randomised controlled trials versus two other anti-@<m>DISEASE_Ototoxicity</m> @DISEASE_MESH:D000081015 @@@angina drugs@@@: @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ and @CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@. ", "citations": {"NLM": "Ivabradine: new drug. Best avoided in stable angina. Prescrire Int. 2007 Apr;16(88):53-6. PMID: 17458043", "BibTeX": "@article{17458043, title={Ivabradine: new drug. Best avoided in stable angina.}, journal={Prescrire Int}, volume={16}, number={88}, pages={53-6}}"}}, {"_id": "10449688", "pmid": 10449688, "title": "Amiodarone protects cardiac myocytes against oxidative injury by its free radical scavenging action.", "journal": "Circulation", "authors": ["Ide T", "Tsutsui H", "Kinugawa S", "Utsumi H", "Takeshita A"], "date": "1999-08-17T00:00:00Z", "doi": "10.1161/01.cir.100.7.690", "meta_date_publication": "1999 Aug 17", "meta_volume": "100", "meta_issue": "7", "meta_pages": "690-2", "score": 50035.773, "text_hl": "@CHEMICAL_Amiodarone @CHEMICAL_MESH:D000638 @@@Amiodarone@@@ decreased the intensity of the DMPO-OH signals in a dose-dependent manner (0.1 to 100 micromol/L), whereas other @<m>DISEASE_Ototoxicity</m> @DISEASE_MESH:D000081015 @@@antiarrhythmia drugs@@@ such as @CHEMICAL_Disopyramide @CHEMICAL_MESH:D004206 @@@disopyramide@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ had no such effects. ", "citations": {"NLM": "Ide T, Tsutsui H, Kinugawa S, Utsumi H, Takeshita A. Amiodarone protects cardiac myocytes against oxidative injury by its free radical scavenging action. Circulation. 1999 Aug 17;100(7):690-2. PMID: 10449688", "BibTeX": "@article{10449688, title={Amiodarone protects cardiac myocytes against oxidative injury by its free radical scavenging action.}, author={Ide T and Tsutsui H and Kinugawa S and Utsumi H and Takeshita A}, journal={Circulation}, volume={100}, number={7}, pages={690-2}}"}}]}